23-27 July 2018
Amsterdam, the Netherlands
The International AIDS Conference brings together science, leadership, and community to advance treatment and prevention of HIV.
Pellet formulation of lopinavir/ritonavir in children: 48-week evolution of viral suppression across age categories in the living study
TB/HIV co-treatment with super-boosted lopinavir and anti-tuberculosis treatment lowers abacavir concentration in children
Whether and why caregivers adhere to oral lopinavir/ritonavir pellets: lessons for scaling up an innovative pediatric HIV treatment in Kenya